This category includes TFE3-rearranged RCC, TFEB-rearranged RCC, TFEB-amplified RCC, FH-deficient RCC, SDH-deficient RCC, ALK-rearranged RCC, ELOC (formerly TCEB1)-mutated RCC, and SMARCB1 (INI1)-deficient RCC. This evidence concerns the gene FH and renal cell carcinoma.